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Normal macrophage function is dependent upon the rapid accumulation and
differentiation of blood-borne monocytes at sites of inflammation in response to
chemoattractants (1) . Phagocytic leukocytes express specific receptors for various
chemoattractants and occupancy of these receptors by agonists leads to chemo-
taxis, 02- production, and lysosomal enzyme secretion (1-6) . The initial cellular
responses stimulated by chemoattractant receptors on polymorphonuclear leu-
kocytes (PMNs)' or monocytes are mediated by a pertussis toxin/choleratoxin-
sensitive guanine nucleotide regulatory (G c) protein (7-14) that activates a
membrane-associated phospholipase C to cleave phosphatidylinositide 4,5-bis-
phosphate (PIP2) into inositol 1,4,5-trisphosphate (IPs)and 1,2-diacylglycerol (8-
14) . IPs mobilizes intracellular calcium, while diacylglycerol activates protein
kinase C (reviewed in references 15-16) . Stimulation of this kinase in phagocytes
appears to trigger 02- production and lysosomal enzyme secretion, since PMA
and synthetic diacylglycerols that activate protein kinase C also initiate these
functions (17-21) . The mechanism for the differentiation of monocytes to
macrophages at inflammatory sites is poorly defined . Biologically however,
inflammatory macrophages have higher levels of microbicidal, tumoricidal, and
phagocytic activities than do blood monocytes (22, 23) .
In other types of cells, activation of protein kinase C by receptor occupancy
or PMA is frequently associated with alterations in the regulation of gene
expression (24-26). Among these genes, protooncogenes c-myc and cfos are of
particular interest . The expression of both genes are transiently induced when
resting cells proliferate in response to mitogens and growth factors (27-30) .
However, during the differentiation of monomyelocytes to macrophages, the
expression of c-myc gene decreases and cfos gene increases (26, 31) . Elevation of
cfos mRNA levels was also observed when pheochromocytoma cells (PC12) were
induced to differentiate to sympathetic neuron-like cells (32) . In addition, in-
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CH, cycloheximide ; diCs, sn-1,2-dioctanoylglycerol ; G protein,
guanine nucleotide regulatory protein ; G,, pertussis toxin/cholera toxin-sensitiveGprotein ; HHBSS,
Hepes-buffered Hank's balanced salt solution ; IP g , inositol 1,4,5-triphosphate; PAF, platelet-activat-
ing factor ; PIP2, phosphatidylinositide 4,5-bisphosphate ; PMN, polymorphonuclear leukocytes.
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FIGURE 1 .
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StructuresofSP6 plasmids used in this study .
For details, see Materials and Methods .
creased cellular cfos mRNA levels causes F9 teratocarcinoma stem cells to
differentiate (33) . These observations suggest that these two genes may be
involved in the regulation of cellular differentiation as well as division .
Little is known, however, about the regulation of expression of these genes in
normal cells . In this study, we show that challenge of nonproliferating, normal
human monocytes with chemoattractants modulates the expression of the cfos
and c-myc genes through a pertussis toxin-sensitive G protein .
Materials and Methods
Reagents .
￿
FMLP, platelet-activating factor (PAF), PMA, actinomycin D, and cyclohex-
imide (CH) were obtained from Sigma Chemical Co . (St . Louis, MO) . Recombinanthuman
IFN-y was a generous gift of Genentech, Inc . (South San Francisco, CA), and partially
purified human colony-stimulating factor was purchased from Genzyme (Boston, MA) .
Preparation of Human Monocytes .
￿
Heparinized venous blood from healthy human
donors was sedimented with 3% dextran for 20 min at room temperature to remove most
of the red cells . Mononuclear cells were then obtained from the leukocyte-rich plasma by
Ficoll-Hypaque gradient centrifugation (34) . These cells were washed three times in
Hepes-buffered Hank's balanced salt solution (HHBSS) ; were divided into 75-mm' tissue
culture flasks in 10 ml RPMI 1640 plus 5% heat-inactivated, pooled human type AB
serum ; and then were incubated for 1 hat 37 °C under 5% C0 2. Nonadherent lymphocytes
were removed by aspirationand adherent monocytes were washed four times with HHBSS .
Isolation of Total RNAfrom Human Adherent Monocytes.
￿
Each flask of adherent mono-
cytes was incubated at 37 °C with 10 ml HHBSS containing 0.5% BSA plus either the
indicated amount of stimulant contained in DMSO or the same amount of DMSO alone .
Cells were lysed in situ with guanidine isothiocyanate solution and total RNA was isolated
after centrifuging through a CsCl cushion (35) . RNA was quantified by optical density at
260 nM .
RNase Protection and Northern Blot Assays .
￿
Three plasmids, each carrying a portion of
human c-myc, cfos or N2-microglobulin genes, were used to generate single-stranded 12p_
labeled RNA probes complementary to mRNA (Fig . 1) . Plasmid pSP65-humyc ex2 (Pst
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I) containing the Pst I fragment of exon 2 of human c-myc gene at Pst I site of plasmid
pSP65 was linearized with restriction endonuclease Hind III before use (36) . Plasmid
pSP65-hu# 2M (5' cDNA) containing an insertion of a 144-bp Pst I-Hinc II fragment of
the 02-microglobulin cDNA clone at Hinc II and Pst I sites of pSP65 was linearized with
Hind III before use (37) . To construct plasmid pSP64-hufos ex4, the 0.75-kb Acc I
fragment derived from exon 4 ofhuman cfos gene was digested with mung bean nuclease
to remove protruding 5' ends and then ligated to Bam HI linkers (38, 39) . This fragment
was digested with enzymes Bam HI and Stu I and the 5' fragment was inserted between
the Bam HI and Hinc II sites ofpSP64 . This plasmid was linearized with Bam HI before
use . Single-stranded "P-labeled RNA probes were generated by in vitro transcription of
linearized plasmids with SP6 polymerase and "P-UTP as described by Melton et al . (40) .
Full-length, labeled RNA transcripts were purified after electrophoresis of reaction
mixtures on 4% polyacrylamide/8 .3 M urea gels .
To perform RNase protection assays, 2 jug oftotal cellularRNA was ethanol precipitated
in the presence of 105 cpm of each antisense RNA probe of c-myc, cfos, and fl-2
microglobulin . Each sample was then dissolved in a 10-,1 hybridization mix (75% form-
amide, 20 mM Tris, pH 7.0, 1 mM EDTA, 0 .4 M NaCI) to hybridize at 60°C for 16-24
h . Excess unhybridized, single-stranded RNA probes were digested in 150 Al of RNase
digestion buffer (0 .3 M NaCl, 10 mM Tris, pH 7 .5, 5 mM EDTA) containing 200 U
RNase T I and 1 .2 gg RNase A at 37'C for 1 h . RNases were removed by the addition
of 10 Al of 10% SDS, and 5 Al of proteinase K (10 mg/ml), and were incubated at 37 °C
for 15 min, followed by phenol/chloroform extraction and RNA precipitation with
ethanol . Samples were finally dissolved in 8 Al formamide loading buffer (39), separated
on 4% polyacrylamide/8 .3 M urea gel, and visualized by autoradiography . The sizes of
protected RNA fragments from human c-myc, cfos, and N2-microglobulin probes are
roughly 420, 230, and 140 bases long, respectively .
Northern transfer was performed as described (41) . Cytoplasmic RNA was denatured
in 50% DMSO, 15% glyoxal, 8.3 mM sodium phosphate buffer, pH 7 .0, at 50°C for 1 h .
The glyoxylated RNA was separated on 1 .2% agarose gel in 10 mM sodium phosphate
buffer, pH 7.0, and then transferred to nitrocellulose paper overnight with 20X SSC (lx
SSC : 0.15 M NaCl, 0.015 M sodium citrate, pH 7.4) . Northern blot filters were hybridized
with nick-translated, 12P-labeled cfos DNA insert of plasmid pSP64-hufos ex4 (42) .
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Preliminary experiments revealed two difficulties in studying gene expression in
human monocytes : (a) The quantity oftotal monocyte RNA that could be isolated
from 1 U of blood is quite limited (60-120 pig) ; (b) The levels of c-myc and cfos
RNA varied from donor to donor . To solve these problems, we routinely
collected 1 U of blood from each oftwo donors for each experiment . Monocytes
prepared from each donor were treated independently, then the RNAs were
isolated and pooled at each time point . The highly sensitive RNase protection
assay was used to measure the levels of RNAs except where indicated . Total
monocyte RNAs were hybridized at the same time with three complementary
RNA probes, and the protected RNA fragments, corresponding to the levels of
c-myc, cfos, or ,82-microglobulin RNA, were then separated on the denaturing
gel due to the size difference .
As shown in Fig . 2, the level of N2-microglobulin RNA was relatively unchanged
during the course of cellular manipulation and was therefore used as an internal
control to monitor the input of total RNAs . Both chemoattractants, FMLP and
PAF, induced the progressive increase of cfos RNA by 6-15-fold over those of
buffer control monocytes at 30 min after treatment, and then decreased toHO ET AL .
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FIGURE 2 .
￿
Kinetics of c-myc, cfos, and #s-microglobulin (,Bs-M) gene expression in human
monocytes in response to chemoattractants . Total cellular RNA was isolated from monocytes
after treatment with 10-s M FMLP (a), or 10-sM PAF (b) for the indicated time intervals .
Specific transcripts were detected by RNase protection assays using 2 Wg total RNA . (- and
+) The absence or presence of chemoattractants, respectively.
slightly above control levels by 4 h . Interestingly, levels of c-mycRNA decreased
by 1 h after exposure to FMLP, and the decrease was even more profound when
monocytes were exposed to PAF. This decrease was reproduced in three inde-
pendent experiments (data not shown) .
Recombinant human IFN-y (20 U/ml) and partially purified human colony-
stimulating factor (10 U/ml) were also tested, and they produced no effects on
the RNA levels of these three genes during the incubation times studied (up to
4 h) (data not shown) .
Protein Kinase C Activators Activate cfos Gene Expression in Human Mono-
cytes. Chemoattractant receptor occupancy in monocytes induces the hydrolysis
of PIP2 to generate the protein kinase C activator diacylglycerol and the intra-
cellular calcium mobilizer IPs (8) . We therefore studied the effects of agents that
mimic these functions to see which secondary signal is involved in the cfos gene
activation . Fig. 3 shows that cfos gene induction kinetics was similar in cells
treated withPMA or sn-1,2-dioctanoylglycerol (diC8) compared to those exposed
to FMLP or PAF. The calcium mobilizer ionomycin (10-7 M) had no effect on
the expression of the cfos, although the ionophore effectively increased the
intracellular calcium concentration and induced a respiratory burst by human
monocytes (data not shown) . Levels of c-myc and 02-microglobulin RNAs re-
mained unchanged upon exposure to either the protein kinase C activators or
ionophore .
Inhibition of Protein Synthesis Elevates the Levels ofBoth cfos and c-myc RNA in
Human Monocytes .
￿
Studies on BALB/c 3T3 fibroblasts and U937 human mon-1528
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FIGURE 3 .
￿
Kinetics of c-myc, cfos, and 02-microglobulin (02-M) gene expression in human
monocytes treated with protein kinase C activators . Total cellular RNA (2 jag) isolated from
monocytes that had been treated with (a) 100 ng/ml PMA or (b) 10-5M diCs for the times
indicated was used in RNase protection assays . (- and +) The absence or presence of the
stimulants, respectively .
ocytic cells have shown that the protein synthesis inhibitorCH plus mitogen or
PMA superinduces the expression of c-myc and cfos gene, respectively, and
treatment of the cells with CH alone leads to the accumulation of these RNAs
(24, 26) . The effect of CH on the RNA levels of these three genes in human
monocytes was determined (Fig . 4) . Both c-mycand cfosRNA gradually increased
to 3- and 15-20-fold, respectively, over the control at 1 h after treatment with
CH . Superinduction of only cfos RNA was observed when monocytes were
treated with both CH and FMLP (or PMA) . The level of cfosRNA in CH plus
FMLP-treated cells reached about fivefold over those treated with CH alone, or
75-100-fold over the level of untreated cells at 1 h after treatment, and then
decreased . This superinduction was even more dramatic when cells were treated
with both CH and PMA. The level of cfos RNA was still increasing at 4 h after
treatment and reached >400-fold over the level of control. There was no
superinduction observed on the level of c-mycRNA andCH had no effect on the
expression of the 02-microglobulin gene .
Increase of cfos RNA Levels in Stimulated Monocytes Is Due to mRNA Accumula-
tion . Northern blot analysis of RNAs obtained at selected incubation time points
was performed to determine whether the increase of cfos RNA observed in the
protection assays was due to accumulation ofmRNAs or nuclear transcripts . Fig .
5 shows similar magnitudes of inductions of mature 2.2-kb cfos mRNA over the
control levels to those determined by RNase protection assays in cells treated
with various stimuli . Furthermore, no accumulation of higher molecular weight
cfosmRNA precursors was detected .HO ET AL .
￿
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FIGURE 4.
￿
Effect of protein synthesis inhibition on the expression of c-myc, cfos, and #2-
microglobulin (N2-M) genes in human monocytes . Adherent humanmonocytes were incubated
with CH (10 Ag/ml) alone or in the presence of 10-6M FMLP (a) or 100 ng/ml PMA (b) .
Total RNA (2 lAg) isolated at the times indicated were used in the RNase protection assay .
and +) Theabsence or presence ofstimulants, respectively .
Activation ofcfosGene Expression by FMLP Is Mediated through a Pertussis Toxin-
sensitive G Protein. Previous studies (7-13) have shown that chemoattractant
receptors stimulate PIP2 hydrolysis via a membrane associated phospholipase C
which is activated through a pertussis toxin-sensitive G protein. Fig . 6 shows
that in vitro preincubation of monocytes with pertussis toxin for 4h completely
inhibited the elevation of cfos RNA levels in response to FMLP . The amount of
pertussis toxin used and the incubation time chosen were those previously
determined to produce maximum G protein ribosylation (7, 10). Inhibition of
gene activation in pertussis toxin-treated cells did not result from nonspecific
toxicity since additional experiments demonstrated the normal induction of cfos
gene expression in pertussis toxin-treated cells when activated by PMA. En-
hancement of cfos gene expression by PMA or FMLP was normal in cells
incubated for 4 h in the ribosylation buffers minus pertussis toxin .
Increased Expression of cfosRNA in Human Monocytes by FMLP or PMA Results1530
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FIGURE 5 .
￿
Northern blot analysis ofcfos transcripts. TotalRNA (6 hg) isolated from control
monocytes or monocytes treated with (a) 10-6M FMLP, (b) 10-6M PMA, (c) 100 ng/ml PMA,
(d) CH (10,ug/ml) alone or CH (10 pg/ml) plus 10-6 FMLP, (e) CH (10,ug/ml) alone or CH
(10 jug/ml) plus 100 ng/ml PMA at the times indicated were separated on agarose gel and
then transferred to nitrocellulose paper . cfos-specific transcripts were detected by hybridiza-
tion to '2P-labeled Bam HI-Hind III cfos fragment of plasmid pSP64-hufos ex4 . The arrow
marks the position of matured 2.2-kb cfos mRNA . (- and +) The absence or presence of
stimulant, respectively .
from Increased Stability and Transcription .
￿
We investigated whether cfosmRNA
accumulation in treated monocytes resulted from transcriptional activation or
stabilization of the messages . Attempts to measure the rate of transcription in
human monocytes by nuclear run-off assays were unsuccessful, perhaps due to
the abundance of proteases in monocytes, which leads to lysis of their nuclei
during conventional isolation procedures. We therefore measured the stability
of cfos, c-myc, and N2-microglobulin RNA by examining the levels of these RNAs
in cells treated with various stimuli in the presence of actinomycin D to block
the de novoRNA transcription . Preliminary experiments revealed that treatment
with actinomycinD (20,ug/ml) inhibited 95% of the incorporation of a-[sH]UTP
into RNA in saponin (50 ug/ml)-permeabilized monocytes (data not shown) . As
shown in Fig . 7, a and b, the levels of cfos and c-myc RNAs declined rapidly with
a half-life of ^-30 min in cells treated with actinomycin D alone . Additional
treatment of cells with CH stabilized both c-myc and cfos RNAs and extended
their half-lives to ^-2 h . The half-life of cfos RNA in FMLP or PMA plus
actinomycin D-treated cells was also slightly extended to ^-1 h. Treatment of
cells with either FMLP orPMA had no effect on the stability of c-mycRNA (Fig .
7 b) .
The stability of cfos RNA in actinomycin D-treated cells exposed to bothHO ET AL .
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FIGURE 6 .
￿
Inhibition of FMLP-induced cfos gene expression in monocytes by pertussis
toxin . Human monocytes were preincubated in HHBSS plus 0.5% BSA in the absence (a) or
presence (b) of pertussis toxin (0.5 ug/ml) at 37 ° C, 5% COY for 4 h . The cells were then
washed withHHBSSand treated with FMLP (5 X 10-7 M) or PMA (100 ng/ml). Total cellular
RNA (1 ug) isolated at the times indicated was used to detect cfos-specific transcripts by RNase
protection assays .
CH and FMLP (or PMA) was also determined . Fig. 7, c and d, show that CH
alone greatly increased the stability of cfos RNA and incubation at the same
time with fMet-Leu-Phe or PMA slightly enhanced cfos RNA stability .
The comparison of the ratios of cfos RNA levels in cells treated with stimuli
to cells without stimuli but in the absence or presence of actinomycin D allows
the assessment of the role of transcriptional activation in the augmentation of
the RNA level. For example, the ratio of cfos RNA in FMLP- or PMA-treated
cells without actinomycin D was 2-10-fold higher than that in cells treated with
FMLP or PMA plus actinomycin D 1 h after treatment . This suggests that the
activation of transcription may be an important factor in the elevation of cfos
RNA level in cells treated with chemoattractant or PMA (Fig . 7 b) .
The relative transcriptional activities of c-myc, cfos, and ,B2-microglobulin genes
in untreated human monocytes was also assessed . The levels of c-myc RNAs
decreased more dramatically than those of cfos RNA in actinomycin D-treated
cells compared with control cells (Fig . 7) . This suggests that the c-myc gene is
more actively transcribed than the cfos gene in unstimulated human monocytes .
In contrast, the levels of N2-microglobulin RNA remained unchanged for 2 h in
the presence or absence of actinomycin D (data not shown), which implies that
the transcription rate of this gene is very low and the half-life of this RNA is at
least >2 h in human monocytes .
Discussion
Occupancy of chemoattractant receptors on phagocytes by chemoattractants
initiates cellular responses that are essential for normal human function and
wound healing (1, 22, 23) . Recently, substantial progress has been made toward
understanding the biochemical mechanisms of the signal transduction through1532
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FIGURE 7 .
￿
Effect of various stimuli on the stabilities of c-myc and cfos RNAs in human
monocytes . Adherant human monocytes were untreated or treated with (a) CH (10 /Ag/ml),
(b) FMLP (10-6 M) or PMA (100 ng/ml), (c) CH (10 lag/ml) alone or CH (10 ug/ml) plus
FMLP (10-6 M) or PMA (100 ng/ml) in the absence (indicated as control) or presence of
actinomycin D (20 ug/ml) for the indicated times . Theabundance of c-mycand cfosRNA was
determined by RNase protection assays using total cellular RNA(2 wg) isolated at the indicated
times . The ratios between the densities of protected RNA probes in treated cells over those
of untreated cells are indicated under each time point . (b) To enhance the detail, the
autoradiographs of protected c-mycRNA probes in the right panels were exposed longer.
chemoattractant receptors . Apparently, phagocytes use the products of poly-
phosphoinositide hydrolysis as intracellular secondary messengers during cellular
activation, since blockage of phospholipase C activation by inactivation of a
pertussis toxin-sensitive G protein abrogates all cellular responses to chemoat-
tractants (7-13) . In addition, chemicals that mimic the activities of diacylglycerol
and IP 3 also stimulate many similar cellular activities (17-21) . Here we examined
whether occupancy of chemoattractant receptors also regulates the expression
of certain genes . These studies demonstrate that all agonists that can activate
protein kinase C in monocytes elevated cfos mRNA levels, suggesting a role for
protein kinase C in controlling gene expression in these cells . Additionally, the
chemoattractants FMLP and PAF decreased the level of c-myc RNA at 1 h after
treatment, a phenomenon not observed during activation of cells with PMA,
diacylglycerol, or calcium ionophore . This observation implies that there are
additional intracellular signal(s) generated by chemoattractant receptor occu-HO ET AL .
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pancy that are capable of regulating gene expression . The persistence of super-
induction by FMLP vs . PMA in CH-treated cells was also very different . Whereas
FMLP plus CH was associated with a gradual decrease of cfos RNA after 1 h,
the level of cfos RNA continued to rise even after 4 h of exposure to PMA plus
CH . This observation further illustrates the differences in gene expression
initiated by chemoattractant receptors vs . PMA. However, the induction kinetics
of the cfos gene were similar in FMLP- and PMA-treated cells. Thus, different
signals appear to downregulate the level of cfos RNA after chemoattractant
receptor occupancy vs . direct protein kinase C activation, as the negative regu-
latory mechanism induced by the former but not the latter is resistant to
inhibition of protein synthesis .
The biological significance of cfos gene activation in human monocytes is not
clear. Presumably, the pattern of gene expression in response to protein kinase
C activation in various cells is associated with distinct modulatory signals . For
example, in PMA-treated rat pituitary cells, there is induction in the expression
of the prolactin gene but not the cfos gene (27) . In various fibroblasts, both c-
fos and c-myc genes are activated by PMA as well as by mitogens that stimulate
phosphoinositide hydrolysis . Additionally, the expression of c-myc is decreased
and cfos is increased when the human monomyelocytic cell linesHL60 or U937
are induced to differentiate to macrophages (26) . This latter modulation pattern
of gene expression resembles that observed during chemoattractant receptor
occupancy of human monocytes . Thus, chemoattractants appear to initiate
differentiation signals in monocytes at the genetic level . This process may be an
initial mechanism for the rapid stimulation of monocyte-to-macrophage differ-
entiation at sites of inflammation . However, recent studies (43) have shown that
transient high-level expression of the cfos gene in U937 cells induced by serum
or diacylglycerol is insufficient to commit the cells to differentiate to macro-
phages . Moreover, these is no cfos gene activation during the differentiation of
certain HL-60 variants . These results, in neoplastic cell lines, imply that cfos
gene activation may not be absolutely required for the differentiation ofmono-
myelocytes to macrophages, and there are response(s) other than induction of c-
fos gene involved in this differentiation (43) . Alternatively, augmentation of c-
fosgene expression may be a sufficient signal for differentiation of nonneoplastic
monocytes or may serve as a priming signal for cells to acquire functional
competence to further stimulation by other signals . To determine the precise
role of cfos gene expression in monocytes it will be necessary to selectively
augment or block the activity of this gene by transfecting cells with a functional
cfos gene or by generating cfos antisense RNA (44), respectively .
The measurement of gene activation in the presence or absenceof actinomycin
D revealed that chemoattractants and protein kinase C activators regulate the
level of cfosRNA by altering both the rate of transcription and message stability .
If there were no transcriptional activation in cells treated with the various stimuli
and the accumulation of cfos or c-myc RNA resulted only from the increased
stability of these RNAs, the magnitude of increase of cfos or c-myc RNA should
have been the same in the presence or absence of actinomycin D. On the other
hand, if there were transcriptional activation in treated cells, the magnitude of
induction of cfos or c-myc RNA by various stimuli would be higher in cells1534
￿
CHEMOATTRACTANTS INCREASE Cfos EXPRESSION IN MONOCYTES
without actinomycin D, since the RNase protection assay measures the level of
both nuclear precursors and cytoplasmic RNAs . As shown in Fig . 7a, the ratio
of increase of cfos RNA in cells treated with CH alone was higher at 2 h after
treatment compared with that of cells treated with both CH and actinomycin D.
In Fig. 7 b, the difference of ratios of cfosRNA level in cells treated with FMLP
or PMA in the absence of actinomycin D compared with those stimulated in the
presence of actinomycin D was even more dramatic . These results suggest that
the effect ofFMLP, PMA, or CH on the accumulation of cfosRNA results from
both transcriptional activation and stabilization of messages . In FMLP- or PMA-
treated cells, transcriptional activation appears to contribute more to the eleva-
tion of the cfos RNA level, while stabilization plays a more critical role in CH-
treated cells . Furthermore, it also implies that the superinduction of cfos RNA
in both CH and FMLP- (or PMA-) treated cells results from the additive effect
of both transcriptional modulation and message stabilization . This conclusion is
further supported by the observation that CH plus FMLP (or PMA) did not
superinduce the stability of cfos RNA since in the presence of actinomycin D
the half-life of message was not prolonged (Fig . 7, c and d) . Thus, the increase
of cfos RNA during superinduction must in part come from transcriptional
activation by FMLP or PMA .
The molecular mechanisms by which chemoattractants decrease the levels of
c-mycRNA can also be assessed from the actinomycin D experiments . As shown
in Fig . 7 b, the ratios of c-myc RNA levels in cells treated with FMLP gradually
decrease compared with those of untreated cells . This downregulation of c-myc
RNA level was not observed in cells treated with FMLP in the presence of
actinomycinD. Theseobservations suggest that theeffect ofFMLP on decreasing
c-mycRNA levels may result from inactivation of cfos gene transcription .
The molecular signal(s) that were generated in monocytes by FMLP or PMA
to activate the transcription of cfos gene is not known . However, recent studies
(45-47) have identified a trans-acting factor in nuclear extracts that binds to the
cfosenhancer sequence within the cfospromoter . The enhancer-binding activity
of this factor was induced by epidermal-growth-factor treatment of A431 epi-
dermal carcinoma cells, and the rate of cfos gene transcription is increased
concomitantly. This observation suggests that the nuclear factor may play a role
in regulation of the cfos gene transcription. Whether a similar nuclear trans-
acting factor(s) is present in monocytes that can be modulated by the chemoat-
tractant FMLP (i .e ., via activation of protein kianse C or other kinases) to
regulate the expression of cfos or c-myc genes remains to be investigated .
We were surprised that the magnitudeof increase of c-mycRNA in cells treated
with both CH and actinomycin D was slightly higher than those treated with CH
alone. This suggests that the effect ofCH on c-mycRNAaccumulation is primarily
enhancement of message stability . At this point, we have no explanation for the
further stabilizing effects of actinomycin D on c-myc RNA.
Interestingly, treatment of monocytes with FMLP orPMA selectively stabilized
cfos RNA but not c-myc RNA. These results resemble the recent observations
(48) that PMA selectively stabilizes granulocyte/monocyte colony-stimulating
factor mRNA in T cells . It is possible that protein kinase C inactivates certain
sequence-specific ribonucleases in the cells . Alternatively, activation of proteinWe would like to thank Ms . Chandhana Yaemsiri for her technical assistance, Dr . John
Murray for critical reading of the manuscript, Dr . Margrith Verghese for helpful discus-
sion and advice, and Ms . Sharon Goodwin for her secretarial assistance .
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kinaseC may compartmentalize cfos RNA to certain intracellular pools that are
less accessible to ribonucleases .
The data presented in this paper indicate that cfos and c-myc gene expression
is finely regulated by chemoattractants in human monocytes . These cells must
rapidly differentiate to macrophages to function normally and do not divide
under ordinary circumstances . Thus, in addition to producingsignals that trigger
the immediate response of monocytes to inflammatory stimuli (i.e ., chemotaxis,
activation of the respiratory burst), chemoattractant receptors also modulate the
expression ofgenes capable of affecting cellular differentiation .
Summary
Human monocytes use the products of phosphoinositide hydrolysis (1,2-diac-
ylglycerol and inositol 1,4,5-triphosphate) as second messengers to trigger rapid
cellular activation during the occupancy ofchemoattractant receptors . The effect
of chemoattractants on modulation of gene expression in monocytes was exam-
ined in this study . The chemoattractants FMLP and platelet-activating factor
induced the progressive increase of cfosRNA to 6-15-fold over those of control
within 30 min after treatment . Similar kinetics ofcfos gene activation was also
observed when cells were treated with PMA or sn-1,2-dioctanoylglycerol, but
not with the calcium mobilizer ionomycin, suggesting a role for protein kinaseC
in gene regulation by chemoattractant receptors. Activation of cfos gene expres-
sion by FMLP is mediated through a pertussis toxin-sensitive G protein, since
pertussis toxin treatment of the cells blocked the induction of the cfos gene by
FMLP but not PMA. The level of c-myc RNA was slightly decreased after 1 h of
treatment with chemoattractants, but not with PMA or diacylglycerol . This
implies that chemoattractant receptor occupancy generates signals beyond pro-
tein kinaseC activation that are capable of selectively downregulating monocyte
gene expression . The effect of FMLP and PMA on the accumulation of cfos
RNA appears to result from altering both the rate of transcription and message
stability . These observations indicate that signals generated through chemoat-
tractant receptor occupancymay regulate monocyte function at the genetic level .
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